COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,398 Articles (22,816 medRxiv, 8,582 bioRxiv)

Most recent first Previous |  Page 690: Articles 6891-6900  | Next

The Defenders of the Alveolus Succumb in COVID-19 Pneumonia to SARS-CoV-2, Necroptosis, Pyroptosis and Panoptosis
Schifanella, L., Anderson, J., Wieking, G., Southern, P. J., Antinori, S., Galli, M., Corbellino, M., Lai, A., Klatt, N., Schacker, T., Haase, A. T.
10.1101/2022.08.06.503050 — Posted: 2022-08-08
Evolutionary progression of collective mutations in Omicron sub-lineages towards efficient RBD-hACE2: allosteric communications between and within viral and human proteins
Barozi, V., Edkins, A. L., Tastan Bishop, O.
10.1101/2022.08.06.503019 — Posted: 2022-08-08
Differential immune response induced by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial
Galvez, N. M. S., CoronaVacCL03 Study Group, , Pacheco, G. A., Schultz, B. M., Melo-Gonzalez, F., Soto, J., Duarte, L. F., Gonzalez, L. A., Rivera, D. S., Rios, M., Berrios, R. V., Vazquez, Y., Moreno-Tapia, D., Vallejos, O. P., Andrade, C. A., Hoppe-Elsholz, G., Iturriaga, C., Urzua, M., Navarrete, M. S., Rojas, A., Fasce, R., Fernandez, J., Mora, J., Ramirez, E., Gaete-Argel, A., Acevedo, M., Valiente-Echeverria, F., Soto-Rifo, R., Weiskopf, D., Grifoni, A., Sette, A., Zeng, G., Meng, W., Gonzalez-Aramundiz, J. V., Goldblatt, D., Gonzalez, P. A., Abarca, K., Bueno, S. M., Kalergis, A. M.
10.1101/2022.08.05.22278464 — Posted: 2022-08-08
Who is pregnant? defining real-world data-based pregnancy episodes in the National COVID Cohort Collaborative (N3C)
Jones, S., Bradwell, K. R., Chan, L. E., Olson-Chen, C., Tarleton, J., Wilkins, K. J., Qin, Q., Groene Faherty, E., Lau, Y. K., Xie, C., Kao, Y.-H., Liebman, M. N., Mariona, F., Challa, A., Li, L., Ratcliffe, S. J., McMurry, J. A., Haendel, M. A., Patel, R. C., Hill, E. L.
10.1101/2022.08.04.22278439 — Posted: 2022-08-08
Two years of COVID-19 Pandemic: Framework of Health Interventions in a Brazilian City
Faioes, V. d. S., Povoa, H. C. C., Thurler, B. A., Chianca, G. C., Assaf, A. V., Iorio, N. L. P. P.
10.1101/2022.08.05.22278481 — Posted: 2022-08-07
Heterologous vaccination as a strategy to minimize inequity in COVID-19 vaccine access: A modeling study in Thailand
Anupong, S., Chantanasaro, T., Wilasang, C., Jitsuk, N. C., Sararat, C., Sornbundit, K., Pattanasiri, B., Chadsuthi, S., Modchang, C.
10.1101/2022.08.05.22278489 — Posted: 2022-08-07
Rapid threat detection in SARS-CoV-2
Barrett, C. L., Huang, F. W. D., Li, T. J. X., Warren, A. S., Reidys, C. M.
10.1101/2022.08.05.22278480 — Posted: 2022-08-07
Neutralization of Omicron BA.4/BA.5 and BA.2.75 by Booster Vaccination or BA.2 Breakthrough Infection Sera
Wang, X., Ai, J., Li, X., Zhao, X., Wu, J., Zhang, H., He, X., Zhao, C., Qiao, R., Li, M., Cui, Y., Chen, Y., Yang, L., Hu, Z., Xu, C., Zhang, W., Wang, P.
10.1101/2022.08.04.502716 — Posted: 2022-08-06
Early Side Effects after Administration of the 1st Dose of Oxford-AstraZeneca Vaccine
Singh, P., Faisal, A. R., Shah, M. H., Saeed, A., Younas, H., Butt, U. S., Pudasaini, S., Pasha, A. R., Rehman, U.
10.1101/2022.08.04.22278415 — Posted: 2022-08-06
Forecasting COVID-19 activity in Australia to support pandemic response: May to October 2020
Moss, R., Price, D. J., Golding, N., Dawson, P., McVernon, J., Hyndman, R. J., Shearer, F. M., McCaw, J. M.
10.1101/2022.08.04.22278391 — Posted: 2022-08-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).